These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1615580

  • 21. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
    Berns EM, de Boer W, Mulder E.
    Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
    [Abstract] [Full Text] [Related]

  • 22. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
    Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ, Brinkmann AO.
    Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
    [Abstract] [Full Text] [Related]

  • 23. Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.
    Bruckheimer EM, Spurgers K, Weigel NL, Logothetis C, McDonnell TJ.
    J Urol; 2003 Apr; 169(4):1553-7. PubMed ID: 12629413
    [Abstract] [Full Text] [Related]

  • 24. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells.
    Damassa DA, Lin TM, Sonnenschein C, Soto AM.
    Endocrinology; 1991 Jul; 129(1):75-84. PubMed ID: 2055206
    [Abstract] [Full Text] [Related]

  • 25. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line.
    Kirschenbaum A, Ren M, Levine AC.
    Steroids; 1993 Sep; 58(9):439-44. PubMed ID: 8236330
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 Sep; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 30. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

  • 31. Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus.
    Geck P, Szelei J, Jimenez J, Sonnenschein C, Soto AM.
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):41-50. PubMed ID: 10215036
    [Abstract] [Full Text] [Related]

  • 32. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K, Markowski M, Bowen C, Gelmann EP.
    Cancer Res; 2001 Jul 15; 61(14):5611-8. PubMed ID: 11454715
    [Abstract] [Full Text] [Related]

  • 33. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC, Gilrain JT, Bradshaw D, Myers CE.
    Endocrinology; 1996 Dec 15; 137(12):5230-5. PubMed ID: 8940339
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T.
    J Urol; 2000 Sep 15; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [Abstract] [Full Text] [Related]

  • 36. Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor.
    Lang SH, Miller WR, Duncan W, Habib FK.
    Int J Cancer; 1994 Oct 15; 59(2):235-41. PubMed ID: 7927924
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
    Lu S, Tsai SY, Tsai MJ.
    Endocrinology; 1999 Nov 15; 140(11):5054-9. PubMed ID: 10537131
    [Abstract] [Full Text] [Related]

  • 40. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH.
    Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.